BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 15, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BSD-2000: Phase III started

BSD began an international Phase III trial to evaluate gemcitabine with or without the BSD-2000 Hyperthermia System...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >